Human neuron model identifies potential therapeutic targets for Alzheimer's disease
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates ...
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates ...
Parkinson's disease, the second most common type of progressive dementia after Alzheimer's disease, affects nearly 1 million people in the ...
Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such ...
In a recent study published in the Journal of Alzheimer's Disease, researchers investigated the mild cognitive impairment (MCI) outcomes of ...
A new study conducted by researchers at the University of Eastern Finland discovered that the APP A673T genetic variant, which ...
A recent review published in Biochemical Pharmacology summarized the ongoing research, providing insights into pathophysiology and emerging drugs for Alzheimer’s disease ...
In a recent study published in Nature Aging, researchers characterize the effects of neuronal apolipoprotein E4 (APOE4) on Alzheimer’s disease ...
In Alzheimer's Disease and other neurodegenerative dementias, proteins that normally play a role in healthy brain tissue turn bad, clumping ...
A multicenter, randomized, placebo-controlled phase 2a clinical trial has recently been conducted to evaluate the efficacy of a nanotherapeutic compound ...
The association of SARS-CoV-2 infection (NeuroCOVID) with damage to the nervous system is not clearly understood. The non-exclusive mechanisms that ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: [email protected]
© 2023 Sepoy.net